HDL Therapeutics

0 followers


HDL Therapeutics is a commercial-stage biotechnology company with an FDA-approved therapy for reducing coronary atheroma in a rare cardiovascular disease.

Industries

Headquarters

Employees

Links

Org chart

Michael A. Matin
Chairman & CEO

Michael A. Matin

Collapse
H. Bryan Brewer
Chief Scientific Officer
Michael McCann
Chief Commercial Officer
Timothy J. Perlman
Chief Technology Officer
Lori A. Carr
VP, Quality Management & Regulatory Affairs